Economiic Home Method Watch Market RSI Search

Jaguar Health, Inc. JAGX

Sector:

Healthcare

Industry:

Biotechnology

Description:

Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The company also develops Crofelemer for multiple possible follow-on indications, including cancer therapy-related diarrhea; orphan-drug indications for symptomatic relief of diarrhea in infants and children with congenital diarrheal disorders and for adult and pediatric patients for short bowel syndrome with intestinal failure with; supportive care for diarrhea relief in inflammatory bowel diseases; diarrhea-predominant irritable bowel syndrome; and for idiopathic/functional diarrhea. In addition, it develops lechlemer, a second-generation anti-secretory agent for cholera; and Canalevia, an oral plant-based drug candidate to treat chemotherapy-induced diarrhea in dogs and exercise-induced diarrhea in dogs. Jaguar Health, Inc. was founded in 2013 and is headquartered in San Francisco, California.
Jaguar Health, Inc. website

Recent Quarter:

2024-11-13

Upcoming Quarter:

2025-03-31

Annual Reports

Date2024-04-01
Revenue 9,761,000
Net Income -41,300,000
EPS -107.42
Basic Shares 384,473
Diluted Shares 384,473
Report Link
Date2023-04-28
Revenue 11,956,000
Net Income -47,454,000
EPS -36.18
Basic Shares 1,311,551
Diluted Shares 1,311,551
Report Link
Date2022-03-11
Revenue 4,335,000
Net Income -60,251,000
EPS -101.07
Basic Shares 596,154
Diluted Shares 596,154
Report Link
Date2021-03-31
Revenue 9,385,000
Net Income -36,791,000
EPS -214.22
Basic Shares 171,745
Diluted Shares 171,745
Report Link
Date2020-04-03
Revenue 5,775,257
Net Income -38,539,436
EPS -1746.39
Basic Shares 22,068
Diluted Shares 22,068
Report Link
Date2019-04-10
Revenue 4,416,145
Net Income -32,146,057
EPS -15507.02
Basic Shares 2,073
Diluted Shares 2,073
Report Link
Date2018-04-09
Revenue 4,361,186
Net Income -21,968,614
EPS -27256.34
Basic Shares 806
Diluted Shares 806
Report Link
Date2017-02-15
Revenue 141,523
Net Income -14,733,780
EPS -249725.08
Basic Shares 59
Diluted Shares 59
Report Link
Date2016-03-29
Revenue 258,381
Net Income -16,291,550
EPS -479163.24
Basic Shares 34
Diluted Shares 34
Report Link
Date2014-12-31
Revenue 0
Net Income -8,609,575
EPS -204989.88
Basic Shares 42
Diluted Shares 42
Report Link

Annual Ratios

Date2023-12-31
PE -0.08
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-12-31
PE -10.81
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-12-31
PE -46.31
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-12-31
PE -51.37
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2019-12-31
PE -6.19
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2018-12-31
PE -13.94
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2017-12-31
PE -72.70
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2016-12-31
PE -40.63
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2015-12-31
PE -66.56
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2014-12-31
PE -484.05
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2013-12-31
PE 0.00
Dividend Yield 0.00
Payout Ratio: 0.000%

Quarterly Reports

Date2024-11-13
Revenue 3,108,000
Net Income -9,854,000
EPS -1.05
Basic Shares 9,370,136
Diluted Shares 9,370,136
Report Link
Date2024-08-13
Revenue 2,721,000
Net Income -9,492,000
EPS -4.04
Basic Shares 2,349,431
Diluted Shares 2,349,431
Report Link
Date2024-05-14
Revenue 2,351,000
Net Income -9,226,000
EPS -3.48
Basic Shares 2,647,371
Diluted Shares 2,647,371
Report Link
Date2024-04-01
Revenue 2,300,000
Net Income -9,170,000
EPS -0.4
Basic Shares 23,068,423
Diluted Shares 23,068,423
Report Link
Date2023-09-30
Revenue 2,813,000
Net Income -7,778,000
EPS -0.38
Basic Shares 20,739,459
Diluted Shares 20,739,459
Report Link
Date2023-08-14
Revenue 2,676,000
Net Income -12,150,000
EPS -0.69
Basic Shares 17,631,514
Diluted Shares 29,109,440
Report Link
Date2023-05-15
Revenue 1,972,000
Net Income -12,202,000
EPS -2.39
Basic Shares 5,109,609
Diluted Shares 5,109,609
Report Link
Date2023-04-28
Revenue 3,260,000
Net Income -7,380,000
EPS -5.63
Basic Shares 1,311,519
Diluted Shares 1,311,519
Report Link
Date2022-11-14
Revenue 3,150,000
Net Income -12,520,000
EPS -8.83
Basic Shares 1,418,159
Diluted Shares 1,418,162
Report Link
Date2022-08-22
Revenue 2,921,000
Net Income -9,367,000
EPS -8.77
Basic Shares 1,068,267
Diluted Shares 1,068,267
Report Link
Date2022-05-10
Revenue 2,625,000
Net Income -17,986,000
EPS -23.1
Basic Shares 778,512
Diluted Shares 778,512
Report Link
Date2022-03-11
Revenue 2,080,000
Net Income -14,313,000
EPS -23.41
Basic Shares 611,439
Diluted Shares 611,439
Report Link
Date2021-11-17
Revenue 630,000
Net Income -12,192,000
EPS -20.25
Basic Shares 602,071
Diluted Shares 611,203
Report Link
Date2021-08-13
Revenue 385,000
Net Income -14,081,000
EPS -23.57
Basic Shares 597,495
Diluted Shares 600,584
Report Link
Date2021-05-17
Revenue 1,241,000
Net Income -12,009,000
EPS -21.54
Basic Shares 557,405
Diluted Shares 568,472
Report Link
Date2021-03-31
Revenue 2,576,000
Net Income -8,769,000
EPS -51.06
Basic Shares 171,744
Diluted Shares 171,744
Report Link
Date2020-11-16
Revenue 2,773,000
Net Income -7,866,000
EPS -44.01
Basic Shares 178,747
Diluted Shares 178,747
Report Link
Date2020-08-13
Revenue 3,167,000
Net Income -9,238,000
EPS -87
Basic Shares 106,181
Diluted Shares 106,181
Report Link
Date2020-05-15
Revenue 869,000
Net Income -7,936,000
EPS -117.93
Basic Shares 67,297
Diluted Shares 67,297
Report Link
Date2020-04-03
Revenue 1,507,051
Net Income -5,959,383
EPS -270.05
Basic Shares 22,068
Diluted Shares 22,068
Report Link
Date2019-11-14
Revenue 972,779
Net Income -7,555,065
EPS -290.99
Basic Shares 25,963
Diluted Shares 25,963
Report Link
Date2019-08-14
Revenue 1,705,694
Net Income -16,721,117
EPS -3400.67
Basic Shares 4,917
Diluted Shares 4,917
Report Link
Date2019-05-21
Revenue 1,589,733
Net Income -8,303,871
EPS -3788.26
Basic Shares 2,192
Diluted Shares 2,192
Report Link
Date2019-04-10
Revenue 1,595,876
Net Income -12,653,885
EPS -6104.14
Basic Shares 2,073
Diluted Shares 2,073
Report Link
Date2018-11-19
Revenue 1,132,067
Net Income -6,138,352
EPS -5475.78
Basic Shares 1,121
Diluted Shares 1,121
Report Link
Date2018-08-13
Revenue 883,846
Net Income -7,657,183
EPS -7183.1
Basic Shares 1,066
Diluted Shares 1,066
Report Link
Date2018-05-15
Revenue 804,356
Net Income -5,696,637
EPS -5309.07
Basic Shares 1,073
Diluted Shares 1,073
Report Link
Date2018-04-09
Revenue 1,542,041
Net Income -20,207,458
EPS -25071.29
Basic Shares 806
Diluted Shares 806
Report Link
Date2017-11-20
Revenue 1,100,214
Net Income 4,759,844
EPS 7300.37
Basic Shares 652
Diluted Shares 652
Report Link
Date2017-08-09
Revenue 896,521
Net Income -1,805,642
EPS -24400.57
Basic Shares 74
Diluted Shares 74
Report Link
Date2017-05-15
Revenue 822,410
Net Income -4,715,358
EPS -77300.95
Basic Shares 61
Diluted Shares 61
Report Link
Date2017-02-15
Revenue 28,877
Net Income -3,676,611
EPS -62315.44
Basic Shares 59
Diluted Shares 59
Report Link
Date2016-11-14
Revenue 50,357
Net Income -3,415,490
EPS -68309.8
Basic Shares 50
Diluted Shares 50
Report Link
Date2016-08-15
Revenue 24,143
Net Income -3,657,475
EPS -81277.22
Basic Shares 45
Diluted Shares 45
Report Link
Date2016-05-10
Revenue 38,146
Net Income -3,984,204
EPS -94862
Basic Shares 42
Diluted Shares 42
Report Link
Date2016-03-29
Revenue 55,186
Net Income -4,130,821
EPS -121494.74
Basic Shares 34
Diluted Shares 34
Report Link
Date2015-11-13
Revenue 77,666
Net Income -2,960,671
EPS -87078.56
Basic Shares 34
Diluted Shares 34
Report Link
Date2015-08-13
Revenue 63,142
Net Income -5,262,675
EPS -154784.56
Basic Shares 34
Diluted Shares 34
Report Link
Date2015-06-26
Revenue 62,387
Net Income -3,937,383
EPS -112496.66
Basic Shares 35
Diluted Shares 35
Report Link
Date2014-12-31
Revenue 0
Net Income -1,969,080
EPS -46882.86
Basic Shares 42
Diluted Shares 42
Report Link
Date2014-09-30
Revenue 0
Net Income -2,730,261
EPS -65006.21
Basic Shares 42
Diluted Shares 42
Report Link
Date2014-06-30
Revenue 0
Net Income -1,943,754
EPS -46279.86
Basic Shares 42
Diluted Shares 42
Report Link
Date2014-03-31
Revenue 0
Net Income -1,966,480
EPS -46820.95
Basic Shares 42
Diluted Shares 42
Report Link

Quarterly Ratios

Date2024-09-30
PE -0.32
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2024-06-30
PE -0.22
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2024-03-31
PE -0.33
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2023-12-31
PE -5.71
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2023-09-30
PE -10.40
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2023-06-30
PE -11.23
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2023-03-31
PE -3.94
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-12-31
PE -17.37
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-09-30
PE -19.88
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-06-30
PE -37.72
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-03-31
PE -34.50
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-12-31
PE -49.98
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-09-30
PE -126.11
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-06-30
PE -226.30
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-03-31
PE -282.00
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-12-31
PE -53.88
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-09-30
PE -22.20
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-06-30
PE -18.81
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-03-31
PE -13.74
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2019-12-31
PE -10.01
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2019-09-30
PE -15.20
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2019-06-30
PE -4.80
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2019-03-31
PE -19.33
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2018-12-31
PE -8.86
Dividend Yield 6.69
Payout Ratio: -237.081%
Date2018-09-30
PE -36.25
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2018-06-30
PE -46.71
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2018-03-31
PE -130.11
Dividend Yield 0.03
Payout Ratio: -17.466%
Date2017-12-31
PE -19.76
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2017-09-30
PE 97.05
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2017-06-30
PE -76.88
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2017-03-31
PE -45.83
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2016-12-31
PE -40.70
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2016-09-30
PE -66.40
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2016-06-30
PE -80.23
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2016-03-31
PE -59.02
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2015-12-31
PE -65.63
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2015-09-30
PE -131.86
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2015-06-30
PE -110.35
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2015-03-31
PE -220.51
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2014-12-31
PE -529.11
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2014-09-30
PE -381.60
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2014-06-30
PE -536.01
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2014-03-31
PE -529.81
Dividend Yield 0.00
Payout Ratio: 0.000%

RSI:

45.62

Price:

$0.98

Market Cap:

11,561,150

EPS TTM:

-8.97

PE Ratio:

-0.24

PEPSG:

NaN

Fwd PE:

NaN

Volume:

278,644

2 Year Price Change

0.002

Index 2 Year Price Change

1.497

5 Year Price Change

0.000

Index 5 Year Price Change

1.905
PESPG: Growth Rate of EPS projected to next quarter and 6 months trailing. Lower is better to help calculate nexts quarters PE Ratio today. Diluted shares effects the EPS reported and makes calculation show as extremely poor expected growth.

Revenue

Net Income

EPS

Shares

News

Press Releases

Notable Earnings

Please select an option: